0001209191-23-058816.txt : 20231215
0001209191-23-058816.hdr.sgml : 20231215
20231215170903
ACCESSION NUMBER: 0001209191-23-058816
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231120
FILED AS OF DATE: 20231215
DATE AS OF CHANGE: 20231215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HEDRICK MARC H
CENTRAL INDEX KEY: 0001203672
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34375
FILM NUMBER: 231491271
MAIL ADDRESS:
STREET 1: C/O CYTORI THERAPEUTICS, INC.
STREET 2: 3020 CALLAN ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PLUS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001095981
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330827593
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4200 MARATHON BLVD.
STREET 2: SUITE 200
CITY: AUSTIN
STATE: TX
ZIP: 78756
BUSINESS PHONE: 737.255.7194
MAIL ADDRESS:
STREET 1: 4200 MARATHON BLVD.
STREET 2: SUITE 200
CITY: AUSTIN
STATE: TX
ZIP: 78756
FORMER COMPANY:
FORMER CONFORMED NAME: CYTORI THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20050712
FORMER COMPANY:
FORMER CONFORMED NAME: MACROPORE INC
DATE OF NAME CHANGE: 20010320
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-20
0
0001095981
PLUS THERAPEUTICS, INC.
PSTV
0001203672
HEDRICK MARC H
C/O PLUS THERAPEUTICS INC.
4200 MARATHON BOULEVARD, SUITE 200
AUSTIN
TX
78756
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-11-20
4
S
0
2068
1.9597
D
170
D
The transactions reflect inadvertent trades made by the reporting person's custodian without authorization.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $1.9601 or $1.9768 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Andrew Sims, as attorney-in-fact
2023-12-15